Michele Libonati

1.6k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

Michele Libonati is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Michele Libonati has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Pathology and Forensic Medicine and 2 papers in Molecular Biology. Recurrent topics in Michele Libonati's work include Multiple Sclerosis Research Studies (3 papers), Immunotherapy and Immune Responses (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Michele Libonati is often cited by papers focused on Multiple Sclerosis Research Studies (3 papers), Immunotherapy and Immune Responses (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Michele Libonati collaborates with scholars based in United States, United Kingdom and Australia. Michele Libonati's co-authors include William Sheremata, Omar Khan, Lance D. Blumhardt, Catherine M. Dalton, David H. Miller, George P. Rice, Katherine Miszkiel, Paul O’Connor, Andrew Goodman and L Metz and has published in prestigious journals such as New England Journal of Medicine, Neurology and Experimental Neurology.

In The Last Decade

Michele Libonati

8 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

2003 936 citations David H. Miller, Omar Khan et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michele Libonati United States	7	626	439	418	219	214	8	1.2k
Laura R. Tranquill United States	16	456 0.7×	694 1.6×	218 0.5×	106 0.5×	241 1.1×	17	1.1k
Cheryl M. Bergman United States	9	255 0.4×	872 2.0×	330 0.8×	66 0.3×	196 0.9×	9	1.3k
Nicolas Molnarfi Switzerland	21	502 0.8×	941 2.1×	240 0.6×	151 0.7×	314 1.5×	30	1.5k
Thomas Prod’homme United States	16	653 1.0×	1.1k 2.5×	302 0.7×	221 1.0×	463 2.2×	26	2.0k
Robert Medaer Belgium	15	616 1.0×	1.1k 2.5×	163 0.4×	97 0.4×	167 0.8×	24	1.4k
Holger Babbe Germany	8	616 1.0×	707 1.6×	217 0.5×	150 0.7×	253 1.2×	8	1.3k
Ludwig Kappos Switzerland	2	1.9k 3.0×	660 1.5×	924 2.2×	607 2.8×	254 1.2×	2	2.5k
Annet F. Wierenga‐Wolf Netherlands	21	475 0.8×	750 1.7×	181 0.4×	158 0.7×	287 1.3×	39	1.5k
Yufen Qin United States	14	289 0.5×	598 1.4×	113 0.3×	104 0.5×	152 0.7×	24	911
H. Wekerle Germany	12	144 0.2×	772 1.8×	142 0.3×	187 0.9×	175 0.8×	21	1.2k

Countries citing papers authored by Michele Libonati

Since Specialization

Citations

This map shows the geographic impact of Michele Libonati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Libonati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Libonati more than expected).

Fields of papers citing papers by Michele Libonati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Libonati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Libonati. The network helps show where Michele Libonati may publish in the future.

Co-authorship network of co-authors of Michele Libonati

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Libonati. A scholar is included among the top collaborators of Michele Libonati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Libonati. Michele Libonati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Hyams, Jeffrey S., David C. Wilson, Adrian G. Thomas, et al.. (2007). Natalizumab Therapy for Moderate to Severe Crohn Disease in Adolescents. Journal of Pediatric Gastroenterology and Nutrition. 44(2). 185–191. 49 indexed citations

2.

Grundy, John S., Subra Kugathasan, Deborah Hilton, et al.. (2005). PHARMACOKINETICS AND PHARMACODYNAMICS OF NATALIZUMAB IN A PHASE 2 STUDY OF ADOLESCENT PATIENTS WITH CROHN'S DISEASE. Journal of Pediatric Gastroenterology and Nutrition. 41(4). 538–538. 7 indexed citations

3.

O’Connor, P., Andrew Goodman, Michele Libonati, et al.. (2004). Randomized multicenter trial of natalizumab in acute MS relapses. Neurology. 62(11). 2038–2043. 117 indexed citations

4.

Vollmer, Timothy R., J. Theodore Phillips, Andrew Goodman, et al.. (2004). An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis. Multiple Sclerosis Journal. 10(5). 511–520. 33 indexed citations

5.

Miller, David H., Omar Khan, William Sheremata, et al.. (2003). A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis. New England Journal of Medicine. 348(1). 15–23. 936 indexed citations breakdown →

6.

Bankiewicz, Krzysztof S., Stuart E. Leff, Dea Nagy, et al.. (1997). Practical Aspects of the Development ofex Vivoandin VivoGene Therapy for Parkinson's Disease. Experimental Neurology. 144(1). 147–156. 41 indexed citations

7.

Tedford, Clark E., et al.. (1992). SCH 39166, a novel dopamine D1 receptor antagonist: In vitro investigation of its glucuronidation and potential species differences. Drug Development Research. 26(4). 389–403. 9 indexed citations

8.

Libonati, Michele & F. Ghiretti. (1959). [Research on cephalotoxin. 2. On some pharmacological properties of the substance].. PubMed. 35. 2003–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact